Advertisement
Screener

Inspire Medical Systems, Inc. (INSP) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

3.3 / 5 stars · 54/81 Roast Me

Inspire Medical Systems, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

Inspire Medical Systems, Inc. (INSP) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-15.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2022-02-15

  • Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2021-03-31 was 0.00%.
  • Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2020-03-31 was 0.00%.
  • Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2019-03-31 was 0.00%.
  • Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2021 was 0.00%.
  • Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2020 was 0.00%.
  • Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2019 was 0.00%.
  • Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2018 was 0.00%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month
2021-12-310.00%
10-K · filed 2022-02-15
2021-09-300.00%
10-Q · filed 2021-11-02
2021-06-300.00%
10-Q · filed 2021-08-03
2021-03-310.00%
10-Q · filed 2021-05-04
2020-12-310.00%
10-K · filed 2021-02-24
2020-09-300.00%
10-Q · filed 2020-11-02
2020-06-300.00%
10-Q · filed 2020-08-04
2020-03-310.00%
10-Q · filed 2020-05-05
2019-12-310.00%
10-K · filed 2020-02-25
2019-09-300.00%
10-Q · filed 2019-11-05
2019-06-300.00%
10-Q · filed 2019-08-06
2019-03-310.00%
10-Q · filed 2019-05-07
2018-12-310.00%
10-K · filed 2019-02-26
2018-09-300.00%
10-Q · filed 2018-11-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
NovoCure Ltd (NVCR)$1.886B-11.87
LEMAITRE VASCULAR INC (LMAT)United States$1.848B33.37
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77